Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections
- PMID: 2712546
- PMCID: PMC171438
- DOI: 10.1128/AAC.33.1.128
Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections
Abstract
Thirty-seven patients with methicillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55% of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
